Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Safestore comfortable with outlook after 'robust' first half

(Sharecast News) - Self storage operator Safestore saw a slight dip in interim underlying profits due to declines in occupancy levels and rental rates, but said it remains "comfortable" with full-year expectations, with third-quarter trends consistent with the first half. Frederic Vecchioli, Safestore's chief executive, said the company delivered a "robust first-half performance while investing in the future growth pipeline", with four new stores set to open in the second half, and 16 new stores earmarked for next year and beyond.

"Safestore in the UK is facing well documented inflationary cost headwinds, but we have identified cost savings which will help mitigate some of the impact of these in the full year and into next year," Vecchioli said.

Underlying EBITDA totalled £66.1m over the six months to 30 April, down 1.5% over last year despite a 3.3% increase in revenues to £112.8m.

While the current lettable area expanded by 6.6% to 8.58m square feet, the occupancy level fell 1.8 percentage points to 74.4% of the current lettable area. The average storage rate also fell to £29.98/sq ft from £30.16/sq ft.

Statutory operating profits were down 39.4% at £112.9m as a result of a lower gain from investment properties revaluation, which fell to £49.5m from £121.7m last year.

Shares were up 3.6% at 646/5p by 0810 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.